BsAbs: Moving from Curiosity to Confidence – [Podcast] Ep. 229

Indications for the use of bispecific antibodies (BsAbs) are rapidly increasing in oncology. While many cancer centers are keeping an eye on this developing field, curiosity must be transformed into proactive planning to avoid being caught unprepared as BsAb indications expand. In this episode, CANCER BUZZ speaks with Laura Kuzma, MSW, admin administrative director of FirstHealth Cancer Center and Oncology Services at FirstHealth Moore Regional Hospital, about the real-world lessons she has learned about governance considerations, ramp-up strategies, and workflows. She shares the importance of proactively building workflows, readiness plans, and cross-team communication pathways to safely operationalize BsAb therapy.

“That was the biggest hesitancy: are we equipped to manage this type of care in this type of setting?”

“My request to the hospital administrators was to allow me to put together a team across the hospital to fully explore the financial side as well as the medical management side.”

“We had doctors in every area of the hospital on this. They cared about it, and I think it was exciting to them too. They felt like they were doing something meaningful, and their input was taken seriously.”

Guest:

Laura Kuzma, MSW
Administrative Director, Oncology Services and Clinical Trials
FirstHealth Moore Regional Hospital
Pinehurst, NC

Resources:

• A Blueprint for Successful Integration of Bispecific Antibodies
• Delivery Models for Administering T-Cell-Engaging Bispecific Antibodies
• Deliverying T-Cell-Engaging Bispecific Antibodies: Frequently Asked Questions (FAQ)
• ACCC Office Hours Recording - Bispecific Antibodies: One BiTE at a Time
• Bispecific Antibodies Checklist for Community Providers
• Using Bispecific Antibodies in Community Practice: Challenge and Opportunities
• Expanding Access to Cellular and Bispecific Therapies: Considerations and Recommendations